相关实验视频

Updated: Jun 17, 2025

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

基于IL-2的癌症免疫疗法:一个不断变化的范式

Sushama Rokade¹, Anita Mehta Damani¹, Martin Oft¹

¹Development Department, Synthekine, Menlo Park, CA, United States.

Frontiers in immunology

|August 8, 2024

概括

干白素-2 (IL-2) 免疫疗法对癌症治疗有希望,但面临着局限性. 新型工程策略和组合疗法正在开发中,以提高疗效和降低毒性,以获得更好的患者结果.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

互白素-2 (IL-2) 是免疫调节,T细胞扩张和耐受性的关键细胞因子.
高剂量IL-2是细胞癌和黑色素瘤的早期免疫疗法,在一些患者中产生持久反应.
野生型IL-2疗法因半衰期短,血管毒性以及对调节性和效应性T细胞的影响而受到限制.

研究的目的:

审查IL-2在癌症治疗中的生物特征,疗效和毒性.
探索新的工程策略和组合疗法,以增强IL-2的治疗潜力.
讨论开发更安全的IL-2基免疫疗法用于癌症治疗.

主要方法:

对IL-2生物学,受体相互作用和临床应用的现有文献的审查.
对IL-2在癌症中的疗效和毒性进行临床前和临床数据的分析.
探索涉及IL-2的新兴工程方法和组合策略.

主要成果:

IL-2在免疫反应中起着至关重要的作用,但在癌症治疗中具有临床限制.
工程策略和组合疗法 (例如,PD-1/L1阻塞) 显示出克服IL-2的毒性和提高抗瘤功效的潜力.
尽管存在挑战,但IL-2仍然是开发改进的癌症免疫疗法的焦点.

结论:

新的IL-2工程和组合方法对于实现其在瘤学中的全部治疗潜力至关重要.
解决IL-2的毒性和优化其免疫调节作用是开发更安全,更有效的癌症治疗的关键.
对基于IL-2的免疫疗法的进一步研究有望改善各种癌症患者的治疗结果.

关键词:

在IL-2中,IL-2被认为是IL-2.在IL-2受体.在IL-2毒性方面,IL-2有毒性 IL-2 变体的IL-2 变体.癌症免疫疗法免疫疗法组合疗法治疗组合治疗.型病毒型病毒

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...